Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Roy Geoffrey Sargent Insider Profile
4 Followers
Roy Geoffrey Sargent, Chief Scientific Officer at GeneTether Therapeutics, Inc., holds 775.00K shares in GeneTether Therapeutics, Inc. (Ticker: TSE:GTTX).
Roy Geoffrey Sargent has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Roy Geoffrey Sargent's holdings
Insider Roles
Chief Scientific Officer
Roles that Roy Geoffrey Sargent holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Roy Geoffrey Sargent
Roy Geoffrey Sargent's Trading History
List of latest transactions for each holding click on a transaction to see Roy Geoffrey Sargent's performance on stock
You May Also Like
Roy Geoffrey Sargent insider profile FAQ
What is the percentage of profitable transactions made by Roy Geoffrey Sargent?
The percentage of profitable transactions made by Roy Geoffrey Sargent is ―.
What is the average return per transaction made by Roy Geoffrey Sargent?
The average return per transaction made by Roy Geoffrey Sargent is ―.
What stocks does Roy Geoffrey Sargent hold?
Roy Geoffrey Sargent holds: TSE:GTTX stocks.
What was Roy Geoffrey Sargent’s latest transaction?
Roy Geoffrey Sargent latest transaction was an Uninformative Sell of ―.
What was Roy Geoffrey Sargent's most profitable transaction?
Roy Geoffrey Sargent’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Roy Geoffrey Sargent's role in GeneTether Therapeutics, Inc.?
Roy Geoffrey Sargent's role in GeneTether Therapeutics, Inc. is Chief Scientific Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.